Published in Telemedicine Week, June 12th, 2007
This trend article about University Hospital, Uppsala, Sweden, is an immediate alert from NewsRx to identify developing directions of research.
Study 1: A new study, "Clinical impact of positron emission tomography (PET) with (18F)fluorodeoxyglucose (FDG) in head and neck tumours," is now available. "PET plays an important role in staging, on suspicion of recurrence and for detection of occult primary tumours in the head and neck. Since 1998 we have used positron emission tomography (PET) with (18F)fluorodeoxyglucose (FDG) to assess selected patients," researchers in Uppsala,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Week